Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Lung Cancer Immunotherapy, IO Biomarkers

David Carbone

MD, PhD

🏢The Ohio State University Comprehensive Cancer Center🌐USA

Professor of Medicine and Director, James Thoracic Center

62
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Dr. David Carbone is a leading thoracic oncologist and lung cancer genomics expert who has made seminal contributions to validating PD-L1 and TMB as companion diagnostics. He led the CheckMate-026 trial examining nivolumab in PD-L1-selected NSCLC and has contributed extensively to understanding why some biomarker-selected patients fail to respond to checkpoint inhibitors.

Share:

🧪Research Fields 研究领域

PD-L1 scoring systems
lung cancer genomics
IO clinical trials
neoadjuvant immunotherapy
TMB clinical validation

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 David Carbone 的研究动态

Follow David Carbone's research updates

留下邮箱,当我们发布与 David Carbone(The Ohio State University Comprehensive Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment